Development of a tumor-targeting MR contrast agent using the high- affinity folate receptor: Work in progress

Investigative Radiology

Volumn 35, Issue 1, 2000, Pages 50-57

  Konda, Sheela D ^a,b   Aref, Michael ^a,c   Brechbiel, Martin ^d   Wiener, Erik C ^a,b,c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c University of Illinois at Urbana Champaign   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Contrast agents; Dendrimer; Folate; Gadolinium

Indexed keywords

CONTRAST MEDIUM; DENDRIMER; FOLIC ACID; GADOLINIUM PENTETATE DERIVATIVE; GADOTERIDOL; RECEPTOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HUMAN; HUMAN CELL; IMAGING SYSTEM; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TUMOR; PRIORITY JOURNAL; RECEPTOR DENSITY; TUMOR XENOGRAFT;

EID: 0033976955     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200001000-00006     Document Type: Article

References (39)

1. Jain JK. Transport of molecules in the tumor interstitium: A review. Cancer Res 1987;47:3039-3051.
2. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991;22:282-287.
3. Lauffer, RB. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: Theory and design. Chem Rev 1987;87: 901-927.
4. Wikstrom MG, Moseley ME, White DL, et al. Contrast-enhanced MRI of tumors: Comparison of Gd-DTPA and a macromolecular agent. Invest Radiol 1989;24:609-615.
5. Unger E, Winokur T, MacDougall P, et al. Hepatic metastases: Liposomal Gd-DTPA-enhanced MR imaging. Radiology 1989;171:81-85.
6. Tilcock C, Unger E, Cullis P, et al. Liposomal Gd-DTPA: Preparation and characterization of relaxivity. Radiology 1989;171:77-80.
7. Hofmann B, Bogdanov A, Marecos E et al. Mechanism of gadophrin-2 accumulation in tumor necrosis. J Magn Reson Imaging 1999;3: 336-341.
8. Unger EC, Totty WG, Neufeld DM, et al. Magnetic resonance imaging using gadolinium-labeled monoclonal antibody. Invest Radiol 1985;20:693-700.
9. Gohr-Rosenthal S, Schmit-Willich H, Ebert W, et al. The demonstration of human tumors on nude mice using gadolinium-labeled monoclonal antibodies for magnetic resonance imaging. Invest Radiol 1993;28:789-795.
10. Cerdan S, Lotscher HR, Kunnecke B, et al. Monoclonal antibodycoated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magn Reson Med 1989;12:151-163.
11. Zuckier LS, Rodriguez LB, Scharff MD. Immunologic and pharmacologic concepts of monoclonal antibodies. Semin Nucl Med 1989; 12:166-186.
12. Baxter AB, Melnikoff S, Stites DP, et al. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Invest Radiol 1991;26:1035-1040.
13. Reimer P, Weissleder R, Lee AS, et al. Receptor imaging: Application to MR imaging of liver cancer. Radiology 1990;177:729-734.
14. Weissleder R, Lee AS, Khaw BA, et al. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 1992;182:381-385.
15. Weissleder R, Lee AS, Fischman AJ, et al. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: Antibody MR imaging. Radiology 1991;181:245-249.
16. 3-targeted magnetic resonance imaging. Nature Med 1998;4:623-626.
17. Leamon CP, Low PS. Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 1991;88:5572-5576.
18. Leamon CP, Low PS. Cytotoxicity of mormordin-folate conjugates in cultured human cells. J Biol Chem 1992;267:24966-24971.
19. Leamon CP, Pastan I, Low PS. Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. J Biol Chem 1993;268: 24847-24854.
20. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer 1994;73:2432-2443.
21. Weitman SD, Weinberg AG, Coney LR, et al. Cellular localization of the folate receptor: Potential role in drug toxicity and folate homeostasis. Cancer Res 1992;52:6708-6711.
22. Campbell IG, Jones TA, Foulkes WD, et al. Folate-binding protein is a marker for ovarian cancer. Cancer Res 1991;51:5329-5338.
23. Garin-Chesa P, Campbell I, Saigo PE, et al. Trophoblast and ovarian cancer antigen LK26. Am J Pathol 1993;142:557-567.
24. Weitman SD, Lark RH, Coney LR, et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992;52:3396-3401.
25. Miotti S, Canevari S, Menard S, et al. Characterization of human ovarian carcinoma-associated antigens by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer 1987;39:297-303.
26. Veggian R, Fasolato S, Menard S, et al. Immunohistochemical reactivity of a monoclonal antibody prepared against human ovarian carcinoma on normal and pathological female genital tissues. Tumori 1989;75:510-513.
27. Coney LR, Tomassetti A, Carayannopoulos L, et al. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res 1991;51:6125-6132.
28. Weitman SD, Frazier KM, Kamen BA, et al. The folate receptor in central nervous system malignancies of childhood. J Neurooncol 1994;21:107-112.
29. Wiener EC, Brechbiel MW, Brothers H, et al. Dendrimer-based metal chelates: A new .class of magnetic resonance imaging contrast agents. Magn Reson Med 1994;31:1-8.
30. Wiener EC, Konda S, Shadron A, et al. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Invest Radiol 1997;32:748-754.
31. Gor'Kov PL, Harris AB, Lauterbur PC. Immobilization system for rat brain imaging. Proc ISMRM 1998;3:2054.
32. Enochs W, Weissleder R. Organ- and tissue-directed MRI contrast agents. In: Edelman R, Hesselink J, Zlatkin M, eds. Clinical magnetic resonance imaging. Vol. 1. Philadelphia: WB Saunders, 1996; 192-220.
33. Toffoli G, Cernigoi C, Russo A, et al. Overexpression of folate binding protein in ovarian cancers. Int J Cancer 1997;74:193-198.
34. Corona G, Giannini F, Fabris M, et al. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells. Int J Cancer 1998;75:125-133.
35. Storrs RW, Tropper FD, Li HY, et al. Paramagnetic polymerized liposomes as new recirculating MR contrast agents. J Magn Reson Imaging 1995;5:719-724.
36. Rijnboutt S, Jansen G, Posthuma G, et al. Endocytosis of GPI-linked membrane folate-receptor-a. J Cell Biol 1996;132:35-47.
37. Luhrs CA, Slomiany BL. A human membrane-associated folate binding protein is anchored by a glycosyl-phospatidylinositol tail. J Biol Chem 1989;264:21446-21449.
38. Kane MA, Elwood PC, Portilla RM, et al. The interrelationship of the soluble and membrane-associated folate-binding proteins in human KB cells. J Biol Chem 1986;261:15625-15631.
39. Antony AC. The biological chemistry of folate receptors. Blood 1992; 79:2807-2820.